Bio-Rad Laboratories, Inc. (BIO) — Free Cash Flow Yield
Healthcare
| Metric | Value |
|---|---|
| FCF Yield | 5.1% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $375M |
| Market Cap | $7.3B |
| P/E Ratio | 9.7x |
Bio-Rad Laboratories, Inc.'s FCF yield of 5.1% is above the Healthcare sector average (4.9%).
Frequently Asked Questions
What is Bio-Rad Laboratories, Inc.'s (BIO) free cash flow yield?
Bio-Rad Laboratories, Inc.'s (BIO) free cash flow yield is 5.1%. That is above the Healthcare sector average (4.9%).
Is BIO's free cash flow yield good?
At 5.1%, BIO's free cash flow yield is considered fair — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Bio-Rad Laboratories, Inc. generate?
Bio-Rad Laboratories, Inc. generated $375M in free cash flow, against a market cap of $7.3B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →